U.S. Markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.61-0.44 (-1.05%)
At close: 4:00PM EDT

41.61 0.00 (0.00%)
After hours: 4:00PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 367.48
52 Week Low 313.69
50-Day Moving Average 352.31
200-Day Moving Average 343.99

Share Statistics

Avg Vol (3 month) 3512.71k
Avg Vol (10 day) 3891.02k
Shares Outstanding 563.08M
Implied Shares Outstanding 6N/A
Float 40.49M
% Held by Insiders 14.81%
% Held by Institutions 1100.00%
Shares Short (Apr 14, 2021) 48.22M
Short Ratio (Apr 14, 2021) 413.65
Short % of Float (Apr 14, 2021) 419.70%
Short % of Shares Outstanding (Apr 14, 2021) 413.30%
Shares Short (prior month Mar 14, 2021) 48.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 04, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jan 04, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.43%
Return on Equity (ttm)-34.46%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -133.16M
Net Income Avi to Common (ttm)-139.7M
Diluted EPS (ttm)-2.52
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)482.72M
Total Cash Per Share (mrq)7.81
Total Debt (mrq)61.7M
Total Debt/Equity (mrq)12.25
Current Ratio (mrq)14.94
Book Value Per Share (mrq)8.26

Cash Flow Statement

Operating Cash Flow (ttm)-74.64M
Levered Free Cash Flow (ttm)-79.3M